Position in ANVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$527,899
-$24,054 QoQ
Shares Held
283,817
+14.7% QoQ
Ownership
0.666%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 61 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ANVS ranks #355 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ANVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $527,899 | 283,817 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $551,953 | 247,513 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $768,576 | 222,132 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $381,197 | 184,154 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $397,732 | 183,287 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $228,919 | 152,613 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $500,806 | 99,564 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $798,858 | 99,114 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $439,101 | 76,233 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $842,412 | 70,791 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,286,111 | 68,776 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $531,819 | 56,040 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $738,078 | 51,650 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $795,926 | 51,650 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $584,983 | 43,558 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $579,455 | 42,296 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $479,636 | 42,296 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $561,060 | 42,027 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $719,813 | 40,945 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,300,003 | 40,945 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,300,735 | 38,569 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $769,565 | 27,583 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||